Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2021 Earnings Conference Call November 15, 2021 4:00 PM ET Company Participants Jason Finkelstein - SVP, Argot Partners, IR Russell Ellison - President & CEO Russell Skibsted - EVP, CFO & Chief Business Officer Marc Hoffman - Chief Medical Officer Conference Call Participants Raghuram Selvaraju - H.C. Wainwright Operator Good afternoon, ladies and gentlemen, and welcome to the Rockwell Medical Third Quarter 2021 Results Conference Call. As a reminder, this conference ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 38-3317208 (State or other jur ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2021 Earnings Conference Call August 16, 2021 4:30 PM ET Company Participants Jason Finkelstein - Investor Relations, Argot Partners Russell Ellison - President & Chief Executive Officer Russell Skibsted - Executive Vice President, Chief Financial Officer & Chief Business Officer Marc Hoffman - Chief Medical Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Operator Good afternoon ladies and gentlemen, and welcome to the Rockwell Medical Q2 2021 ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Commission File Number: 000-23661 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 38-3317208 (State or other jurisdic ...

| --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | Q1 2021 Financial Results and Business Update ROCKWELL MEDICAL, INC. TRANSFORMING IRON DEFICIENCY AND ANEMIA MANAGEMENT | | | | | | | | | May 17, 2021 | | | | | | | | FORWARD-LOOKING STATEMENTS 2 Certain statements in this presentation may constitute "forward-l ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Claudia Styslinger - Investor Relations Russell Ellison - President and Chief Executive Officer Russell Skibsted - EVP, Chief Financial Officer and Chief Business Officer Marc Hoffman - Chief Medical Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Operator Thank you for standing by and welcome to the Rockwell Medical First Quarter 2021 Results Call. At this time all part ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Form 10-Q or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 38-3317208 (State or other jurisdi ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2020 Earnings Conference Call March 31, 2021 4:30 PM ET Company Participants Claudia Styslinger - IR, Argo Partners Russell Ellison - President and CEO Tim Chole - VP, Marketing Marc Hoffman - CMO Russell Skibsted - EVP, CFO and Chief Business Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to the Rockwell Medical Fourth Quarter and Full Year 2020 Results Call. At this time all particip ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of ...

® ROCKWELL | --- | --- | --- | --- | --- | |---------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | ROCKWELL MEDICAL, INC. | | | | | | TRANSFORMING IRON DEFICIENCY AND ANEMIA MANAGEMENT March 2021 | | | | | FORWARD-LOOKING STATEMENTS 2 Certain statements in this presentation may constitute "forward-looking statements" within the meaning of federal securities laws, including, but not limited to, Rockwell Medical's intention to commercialize Triferic® Dia ...